Medacta Group SA
No trades
4.490 CHF
69.43 M CHF
562.59 M CHF
6.09 M
About Medacta Group SA
Sector
Industry
CEO
Francesco Siccardi
Website
Headquarters
Castel San Pietro
Founded
1999
ISIN
CH0468525222
FIGI
BBG00NPRXKR2
Medacta Group SA engages in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. The firm offers personalized kinematic models and three-dimensional planning tools for use in hip, knee, shoulder, and spine procedures. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XMEM
Xtrackers MSCI Emerging Markets Swap UCITS ETF Capitalisation 1CWeight
0.25%
Market value
2.14 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of 6MD is 151.042 CHF — it has increased by 0.59% in the past 24 hours. Watch Medacta Group SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange Medacta Group SA stocks are traded under the ticker 6MD.
6MD stock has risen by 5.95% compared to the previous week, the month change is a 5.95% rise, over the last year Medacta Group SA has showed a 34.41% increase.
We've gathered analysts' opinions on Medacta Group SA future price: according to them, 6MD price has a max estimate of 175.13 CHF and a min estimate of 149.45 CHF. Watch 6MD chart and read a more detailed Medacta Group SA stock forecast: see what analysts think of Medacta Group SA and suggest that you do with its stocks.
6MD stock is 1.00% volatile and has beta coefficient of 0.98. Track Medacta Group SA stock price on the chart and check out the list of the most volatile stocks — is Medacta Group SA there?
Today Medacta Group SA has the market capitalization of 3.02 B, it has decreased by −0.92% over the last week.
Yes, you can track Medacta Group SA financials in yearly and quarterly reports right on TradingView.
Medacta Group SA revenue for the last half-year amounts to 321.60 M CHF, despite the estimated figure of 317.83 M CHF. In the next half-year revenue is expected to reach 321.04 M CHF.
6MD net income for the last half-year is 56.54 M CHF, while the previous report showed 32.93 M CHF of net income which accounts for 71.67% change. Track more Medacta Group SA financial stats to get the full picture.
Medacta Group SA dividend yield was 0.65% in 2024, and payout ratio reached 19.79%. The year before the numbers were 0.44% and 23.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 11, 2025, the company has 1.91 K employees. See our rating of the largest employees — is Medacta Group SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medacta Group SA EBITDA is 170.09 M CHF, and current EBITDA margin is 26.63%. See more stats in Medacta Group SA financial statements.
Like other stocks, 6MD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medacta Group SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medacta Group SA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medacta Group SA stock shows the buy signal. See more of Medacta Group SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.